A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy

Human Reproduction

Volumn 22, Issue 3, 2007, Pages 858-863

  Kirk, E ^a   Condous, G ^a,b   Van Calster, B ^c   Haider, Z ^a   Van Huffel, S ^c   Timmerman, D ^d   Bourne, T ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Ectopic pregnancy; hCG; Methotrexate; Predictive value

Indexed keywords

ABORTIVE AGENT; CHORIONIC GONADOTROPIN; METHOTREXATE;

ARTICLE; BLOOD; ECTOPIC PREGNANCY; FEMALE; HUMAN; PREDICTION AND FORECASTING; PREGNANCY; PROSPECTIVE STUDY; VALIDATION STUDY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; METHOTREXATE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY, ECTOPIC; PROSPECTIVE STUDIES;

EID: 34247857614     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del433     Document Type: Article

References (15)

1. Condous G, Okaro E, Khalid A, Timmerman D, Lu C, Zhou Y, Van Huffel S and Bourne T (2004) The use of a new logistic regression model for predicting the outcome of pregnancies of unknown location. Hum Reprod 19,1900-1910.
2. Dudley PS, Heard MJ, Sangi-Haghpeykar H, Carson SA and Buster JE (2004) Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertil Steril 82,1374-1378.
3. Gamzu R, Almog B, Levin Y, Avni A, Jaffa A, Lessing JB and Baram A (2002) Efficacy of methotrexate treatment in extrauterine pregnancies defined by stable or increasing human chorionic gonadotrophin concentrations. Fertil Steril 77,761-765.
4. Hanley JA and McNeil B (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143,29-36.
5. Hosmer DW and Lemeshow S (2000) Applied Logistic Regression. Wiley, New York.
6. Lipscomb GH, McCord ML, Stovall TG, Huff G, Portera SG and Ling FW (1999) Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 341,1974-1978.
7. Lipscomb GH, Givens VA, Meyer NL and Bran D (2004) Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy. Fertil Steril 81,1221-1224.
8. Lipscomb GH, Givens VM, Meyer NL and Bran D (2005) Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy. Am J Obstet Gynecol 192,1847-1848.
9. Natale A, Candiani M, Barbieri M, Calia C, Odorizzi MP and Busacca M (2004) Pre- and post-treatment patterns of human chorionic gonadotrophin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol 117,87-92.
10. Saraj AJ, Wilcox JG, Najmabadi S, Stein SM, Johnson MB and Paulson RJ (1998) Resolution of hormonal markers of ectopic gestation: a randomised trial comparing single-dose intra-muscular methotrexate with salpingostomy. Obstet Gynecol 92,989-994.
11. Stovall TG and Ling FW (1993) Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 168,1759-1765.
12. Stovall TG, Ling FW and Gray LA (1991) Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 77,754-757.
13. Takacs P, Rodriguez L, Laibl V, Pietro P and Kang J (2004) Relationship of high pre-treatment folic acid level and failure of methotrexate in ectopic pregnancy: pilot study. J Reprod Med 49,713-716.
14. Takacs P, Chakhtoura N, De Santis T and Verma U (2005) Evaluation of the relationship between endometrial thickness and failure of single-dose methotrexate in ectopic pregnancy. Arch Gynecol Obstet 6,1-4.
15. Tawfiq A, Agameya AF and Claman P (2000) Predictors of treatment failure for ectopic pregnancy treated with single-dose methotrexate. Fertil Steril 74,877-880.